Amrish Oncology Services Private Limited

Amrish Oncology Services Private Limited - healthcare in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U85110GJ2006PTC047555 Incorporated 20 January 2006 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company healthcare MSME · Small
Data last updated
Revenue · FY 2025
₹22.22 Cr
▼ 56% YoY
Net profit · FY 2025
₹20.27 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹2.88 Cr
EBITDA margin 13%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹1.16 Cr
Issued & subscribed
Satisfied charges
₹24.27 Cr
No open charges
Company age
20 yrs
Est. 2006
Employees · EPFO
154
Provident fund records

About Amrish Oncology Services Private Limited

Data last updated:

Amrish Oncology Services Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Dr. Ravi Patel Md Inc.. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 20 January 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85110GJ2006PTC047555. Its GSTIN is 24AAFCA5990B1ZW (Gujarat). The company holds 5 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.16 Cr. It is led by directors Rohan Maheshbhai Naik and Manglesh Dhirubhai Desai.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 3rd Floor 21 Magnet Corporate Park, Ahmedabad, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹22.22 Cr, a decline of 56% compared to the previous year. For the same year it recorded a net profit of ₹20.27 Lakh (net margin 0.9%) and EBITDA of ₹2.88 Cr (EBITDA margin 13%). Revenue has declined at a compounded annual rate (CAGR) of 35% over three years and 13% over five years.

The company has about 154 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary and 1 joint venture.

The company is associated with 1 brand: Comprehensive Blood & Cancer Center. As per MCA filings, the company has satisfied charges of ₹24.27 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 acquisition), with disclosed funding of ₹28.29 Cr; the latest was in October 2023. Its 5 peer companies in the Healthcare industry (Oncology Care), with the same principal business activity (hospital activities) are compared by revenue, 3 larger and 2 smaller; the largest is Buddha Cancer Centre Private Limited with revenue of ₹32.36 Cr. The company has 5 MSME Form 1 returns on record for the period ending Sep 2019, listing 24 overdue payments to 1 micro and small supplier.

Amrish Oncology Services Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-09-0014358). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cbccusa.in.

Company details

CIN U85110GJ2006PTC047555
Registration Number 047555
Incorporation Date 20 January 2006
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Dr. Ravi Patel Md Inc.
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-09-0014358

Recognitions & Rankings of Amrish Oncology Services

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-09-0014358

Contact details

Amrish Oncology Services Private Limited's registered office is in Ahmedabad, Gujarat. Its website is cbccusa.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    3rd Floor 21 Magnet Corporate Park, S G Highway, Ahmedabad, Gujarat, India – 380054
  • Industry
    Healthcare, Oncology Clinics & Cancer Treatment

To see the full contact details of Amrish Oncology Services Private Limited, buy the company report.

Comprehensive company report
Amrish Oncology Services Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Amrish Oncology Services operates one associated brand: Comprehensive Blood & Cancer Center. Each brand links to its own profile.

BrandDescriptionWebsite
Oncology services are delivered via a chain of specialized centers.cbccusa.in

Business activity

The main business activity of Amrish Oncology Services is hospital and medical care. In detail, this covers hospital activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ1Hospital activities

To see the full business activity and turnover split of Amrish Oncology Services Private Limited, buy the company report.

Financials of Amrish Oncology Services Private Limited

FY 2024 filings available

Amrish Oncology Services Private Limited reported revenue of ₹22.22 Cr (down 56% YoY) for FY 2025.

Revenue · FY 2025
₹22.22 Cr ▼ 56%
Net profit · FY 2025
₹20.27 Lakh margin 0.9%
EBITDA · FY 2025
₹2.88 Cr margin 13%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 56%
3 years · compounded
▼ 35%
5 years · compounded
▼ 13%
EBITDA CAGR growth
1 year
▼ 78%
3 years · compounded
▼ 12%
5 years · compounded
▼ 6%

Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 56% fall in the latest year. EBITDA fell 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.88 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹20.27 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin13%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Amrish Oncology Services Private Limited, buy the company report.

Board of directors of Amrish Oncology Services Private Limited

Amrish Oncology Services has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manglesh Dhirubhai DesaiAdditional Director30 Oct 20251 Years 0 MonthsCurrent
Rohan Maheshbhai NaikDirector15 Apr 20242 Years 6 MonthsCurrent

Peer comparison

Amrish Oncology Services Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Oncology Care), with the same principal business activity (hospital activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Buddha Cancer Centre Private Limited₹32.36 Cr (FY 2025)46.0%Asian School, Danapur, Bihar, India
Oncocare Medicals Private Limited₹26.55 Cr (FY 2025)2.0%Kanpur, Uttar Pradesh, India
Starlit Hospitals Private Limited₹23.2 Cr (FY 2025)12.0%Ahmedabad, Gujarat, India
Amrish Oncology Services Private Limitedthis company₹22.22 Cr (FY 2025)₹20.27 Lakh0.9%-56.0%154Ahmedabad, Gujarat, India
Oncoville Private Limited₹21.99 Cr (FY 2024)62.0%Bengaluru, Karnataka, India
Kims Cancer Care and Research Center Private Limited₹20.62 Cr (FY 2018)-2.0%Thiruvananthapuram, Kerala, India

To see the full peer comparison of Amrish Oncology Services Private Limited, buy the company report.

Auditor

Amrish Oncology Services Private Limited is audited by KARRA & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
KARRA & CO.FY 2023001749S

Shareholding

The shareholding of Amrish Oncology Services Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Amrish Oncology Services Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹24.27 Cr
Breakdown by lending institutions
Siemens Financial Services Private Limited₹13.19 Cr
Hdfc Bank Limited₹6.33 Cr
Others₹4.45 Cr
Citibank N. A.₹0.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
10 Oct 2022100625388Hdfc Bank Limited₹93.5 LakhSatisfied
27 May 2020100343751Others₹1.8 CrSatisfied
11 Jan 2019100233534Others₹1.5 CrSatisfied
20 Dec 2016100073879Others₹1.15 CrSatisfied
18 Sep 201310453631Siemens Financial Services Private Limited₹4.47 CrSatisfied

To see the full charge records of Amrish Oncology Services Private Limited, buy the company report.

Total charge records: 11 View all charges

Deals & funding

Amrish Oncology Services Private Limited has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 acquisition), with disclosed funding of ₹28.29 Cr; the latest was in October 2023.

Total deals
6
Funding rounds
3
Secondary share transfers
2
Acquisition
1
Disclosed funding
₹28.29 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Oct 2023Acquisition₹16 CrBuyer: Healthcare Global Enterprises Limited
Seller: Amrish Oncology Services Private Limited
May 2013Funding round₹25 CrInvestors: Prem Investment Limited
Mar 2009Funding round₹2.09 CrInvestors: Ravi Patel MD Inc.
Jul 2007Secondary share transferUndisclosedBuyer: Ravi Patel MD Inc.
Seller: 2 individuals
Dec 2006Funding round₹1.2 CrInvestors: Ravi Patel MD Inc.

To see the full deal history of Amrish Oncology Services Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Amrish Oncology Services Private Limited has 5 MSME Form 1 returns on record for the period ending Sep 2019, listing 24 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
Pradip R Shah & Co.

To see the full MSME payment records of Amrish Oncology Services Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Amrish Oncology Services has 1 subsidiary company and 1 joint venture. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.

1
Subsidiary companies
1
Joint ventures
Key subsidiaries
Company NameCINShares held
Dr. Rai-Cbcc Oncology Services Private LimitedU85110TN2009PTC071583

To see the full group structure of Amrish Oncology Services Private Limited, buy the company report.

Employees & EPFO

Amrish Oncology Services Private Limited has a workforce of 154 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.

Employee count
154
Active EPFO establishments
1
Employee growth
-27.01%

GST

Amrish Oncology Services has 5 GST registrations: 3 active and 2 cancelled or inactive.

Total GSTINs
5
Active
3
Cancelled / inactive
2
GSTINStateStatusRegistered on
24AAFCA5990B1ZWGujaratActive01 Jul 2017
22AAFCA5990B1Z0ChattisgarhActive30 Jul 2017
33AAFCA5990B1ZXTamil NaduActive30 Jul 2017

To see the full GST registrations and return filing status of Amrish Oncology Services Private Limited, buy the company report.

Recent activity

Amrish Oncology Services Private Limited has 22 board changes on record since 2006: 12 appointments and 10 cessations. The latest: Achuthannair Sarathkumar ceased to be Director on 18 Nov 2025.

Ceased
Achuthannair Sarathkumar ceased to be Director.
Ceased
Prem Kumar Menon ceased to be Director.
Ceased
Ravindranath Patel ceased to be Director.
Appointed
Manglesh Dhirubhai Desai was appointed as Additional Director.
Ceased
Sendhil Thyagarajan ceased to be Director.
AGM
Amrish Oncology Services Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Ramesh Balasubramanian ceased to be Whole-Time Director.
Ceased
Madhur Kumar Garg ceased to be Director.
Appointed
Rohan Maheshbhai Naik was appointed as Director.
Filing
Amrish Oncology Services Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge registered on 10 Oct 2022 via Charge ID 100625388 with Hdfc Bank Limited was fully satisfied on 02 Nov 2023.
Appointed
Madhur Kumar Garg was appointed as Director.

36 earlier events are in the company report.

Frequently asked questions

Amrish Oncology Services is an active private limited company based in Ahmedabad, Gujarat, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 20 January 2006 (20+ years old) and is registered under CIN U85110GJ2006PTC047555.

Amrish Oncology Services has 2 current directors:

The latest financial statements of Amrish Oncology Services on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Amrish Oncology Services is 24AAFCA5990B1ZW, registered in Gujarat. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 22AAFCA5990B1Z0 (Chattisgarh), 33AAFCA5990B1ZX (Tamil Nadu).

The CIN (Corporate Identification Number) of Amrish Oncology Services is U85110GJ2006PTC047555. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Amrish Oncology Services has 2 court cases on record: 2 filed against it.

Amrish Oncology Services was incorporated on 20 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Amrish Oncology Services has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 acquisition), with disclosed funding of ₹28.29 Cr; the latest was in October 2023.

The peers of Amrish Oncology Services by revenue are Buddha Cancer Centre Private Limited, Oncocare Medicals Private Limited, Starlit Hospitals Private Limited, Oncoville Private Limited, Kims Cancer Care and Research Center Private Limited, all in the Healthcare industry (Oncology Care), with the same principal business activity (hospital activities).

Achuthannair Sarathkumar ceased to be Director on 18 Nov 2025. Prem Kumar Menon ceased to be Director on 18 Nov 2025. Ravindranath Patel ceased to be Director on 18 Nov 2025. Amrish Oncology Services has 22 board changes on record in total.

Yes, Amrish Oncology Services is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-09-0014358).

Amrish Oncology Services has 5 MSME Form 1 returns on record for the period ending Sep 2019, listing 24 overdue payments to 1 micro and small supplier. The latest return was filed on 03 Apr 2021.